The global Anti-Depressants drugs market size was valued at $16.44Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $26 Bn in 2030. drug class, indication, route of administration, end-user, distribution channel and geography. The global Anti-Depressants drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players are H. Lundbeck A/S (DNK), GlaxoSmithKline plc (GBR), Eli Lilly and Company (USA), Janssen Pharmaceuticals (BEL), Pfizer Inc. (USA), AstraZeneca (GBR), Bristol-Myers Squibb (USA), and others.
The global Anti-Depressants drugs market size was valued at $16.44 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030 and will reach $26 Bn in 2030. Depression is a common mental health disorder characterized by persistent feelings of sadness, loss of interest or pleasure, changes in appetite and sleep patterns, low energy, and difficulty in concentrating. Depression can have a significant impact on an individual's daily life, including their ability to work, socialize, and function in relationships.
According to the World Health Organization (WHO), mental health expenditure is a crucial aspect of the healthcare system, as it determines the availability, accessibility, and quality of mental health services. The WHO recommends that countries allocate at least 5% of their healthcare budget to mental health, but many countries fall short of this target. Global mental health expenditure varies widely across countries and regions. In low-income countries, mental health expenditure is often very low, with many countries spending less than 1% of their healthcare budget on mental health. In contrast, high-income countries tend to spend more on mental health, with some countries spending over 10% of their healthcare budget on mental health.
The prevalence and incidence of depression vary depending on the region, age, gender, and other demographic factors. According to the World Health Organization (WHO), depression is a leading cause of disability worldwide, affecting over 264 Mn people globally. Depression is one of the most common mental health disorders globally, with an estimated 4.4% of the world's population experiencing depression at any given time.
The incidence of depression is highest among young adults, with an estimated 15% of people experiencing depression at some point during their lifetime. Depression is more common among women than men. According to the WHO, the prevalence of depression in women is nearly twice as high as in men. The highest rates of depression are found in the Eastern Mediterranean and Western Pacific regions, while the lowest rates are found in the African region. Depression can have a significant impact on an individual's quality of life, leading to disability, loss of productivity, and increased healthcare costs. It is estimated that depression and anxiety disorders cost the global economy over $1 trillion annually.
One of the primary treatments for depression is the use of antidepressant medications, which are drugs that help regulate mood and reduce symptoms of depression. The market for antidepressant drugs has been growing steadily over the years, driven by the increasing prevalence of depression and the rising demand for effective treatments. The impact of depression on the antidepressant drugs market is significant. As the prevalence of depression continues to increase, the demand for antidepressant drugs is expected to grow. In addition, the growing awareness about mental health issues and the availability of effective treatments are also driving market growth.
Market Growth Drivers Analysis
The antidepressant drugs market is primarily driven by the increasing prevalence of depression and other mental health disorders globally. According to the World Health Organization (WHO), depression is a leading cause of disability worldwide, affecting over 264 million people globally. As a result, there is a growing demand for effective treatments, including antidepressant drugs, to manage the symptoms of depression. The rising awareness about mental health issues and the availability of effective treatments are also driving the market growth.
In addition, the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies are also driving the growth of the market. The increasing investment in research and development activities, the emergence of personalized medicine, and the growing trend of combination therapies are expected to create new growth opportunities for the market.
There are many market restraints as well one of them is the increasing availability of generic versions of antidepressant drugs. Generic drugs are cheaper than branded drugs, which can reduce the overall revenue generated by the market. In addition, the potential side effects of antidepressant drugs, including weight gain, nausea, and dizziness, can affect patient compliance and adherence to treatment.
Moreover, the stringent regulatory requirements for the approval of antidepressant drugs can also pose a challenge to market growth. The complex and time-consuming clinical trials, high development costs, and increasing regulatory scrutiny can delay the approval and launch of new antidepressant drugs.
June 2021: An agreement to jointly develop and market zuranolone (SAGE-217), which is intended for major depressive disorder, postpartum depression, and other psychiatric illnesses, was made public by Sage Therapeutics and Biogen Inc.
February 2021: On-demand mental healthcare provider Ginger recently announced a cooperation with online pharmacy Capsule. This collaboration sought to deliver anti-depressants and other mental health prescriptions to Ginger members at their homes.
November 2020: Biogen Inc and Sage Therapeutics announced a collaboration agreement to develop and commercialize zuranolone (SAGE-217) indicated for major depressive disorder, postpartum depression and other psychiatric disorders.
Policy changes and Reimbursement scenario
Regulations regarding the development, approval, and use of antidepressant drugs differ across the globe, as each country has its own regulatory framework for pharmaceutical products. Here are some examples of the regulatory agencies and guidelines for antidepressant drugs in different regions.
The Food and Drug Administration (FDA) regulates the approval and marketing of antidepressant drugs in the United States. The FDA requires that all new drugs undergo rigorous clinical trials to demonstrate their safety and efficacy before they can be approved for marketing. The FDA also requires that antidepressant drug labels include warnings about potential side effects, including the risk of suicidal thoughts and behavior.
In the United States, most antidepressant drugs are covered by private insurance plans and government programs such as Medicare and Medicaid. The extent of coverage and cost-sharing requirements may vary depending on the specific insurance plan or program.
The European Medicines Agency (EMA) is responsible for the evaluation and approval of antidepressant drugs in the European Union. The EMA requires that all new drugs undergo clinical trials to demonstrate their safety and efficacy before they can be approved for marketing. The EMA also requires that antidepressant drug labels include warnings about potential side effects, including the risk of suicidal thoughts and behavior.
In the European Union, reimbursement policies for antidepressant drugs vary by country. Most European countries have a national healthcare system that covers the cost of antidepressant drugs for eligible patients. However, the specific reimbursement policies and cost-sharing requirements may vary depending on the country.
The Pharmaceuticals and Medical Devices Agency (PMDA) regulates the approval and marketing of antidepressant drugs in Japan. The PMDA requires that all new drugs undergo clinical trials to demonstrate their safety and efficacy before they can be approved for marketing. The PMDA also requires that antidepressant drug labels include warnings about potential side effects, including the risk of suicidal thoughts and behavior.
The National Medical Products Administration (NMPA) regulates the approval and marketing of antidepressant drugs in China. The NMPA requires that all new drugs undergo clinical trials to demonstrate their safety and efficacy before they can be approved for marketing. The NMPA also requires that antidepressant drug labels include warnings about potential side effects, including the risk of suicidal thoughts and behavior.
1. Report Description of the Global Anti-Depressants Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reasons to buy the report
2. Global Anti-Depressants Drugs Market Executive Summary
2.1 Global Anti-Depressants Drugs Market - Market Overview
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of the Global Anti-Depressants Drugs Market
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4. Global Anti-Depressants Drugs Market Segmentation
4.1 Drug Class
4.1.1 Tricyclic Antidepressants (TCAs)
4.1.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
4.1.3 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
4.1.4 Monoamine Oxidase Inhibitors (MAOIs)
4.1.5 Serotonin Antagonist and Reuptake Inhibitors (SARI)
4.2.1 Major Depressive Disorder
4.2.2 Anxiety Disorders
4.2.3 Attention Deficit Hyperactivity Disorder
4.3 Route of Administration
4.4.3 Speciality Centres
4.5 Distribution Channel
4.5.1 Hospital Pharmacy
4.5.2 Online Pharmacy
4.5.3 Retail Pharmacy
5. Global Anti-Depressants Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Global Healthcare Policies
8.2 Regulatory Framework
8.3 Pricing & Reimbursement Scenario in Global Anti-Depressants Drugs Market
9. Factors Driving Future Growth
9.1 New Trends and Development in Global Anti-Depressants Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations
The market is divided into monoamine oxidase inhibitors, atypical antidepressants, tricyclic, serotonin, and norepinephrine reuptake inhibitors, selective serotonin reuptake inhibitors, and others based on pharmacological class. In 2021, the selective serotonin reuptake inhibitors (SSRIs) market segment held the biggest market share. The strength of the pipeline of top players to assess new potential candidates in this drug class, combined with the clinical advantage of SSRIs over conventional medications in the management and treatment of depression, is anticipated to accelerate the segment's growth.
By Indication, the major depressive disorder segment was the major contributor in 2021 and is expected to maintain its lead during the forecast period, owing to an increase in the prevalence of major depressive disorder and initiatives taken by governments and private organizations about the development of drugs. However, the obsessive-compulsive disorder segment is expected to witness considerable growth during the forecast period, owing to an increase in the prevalence of mental disorders and an increase in the number of approval for anxiety drugs.
Route of Administration
Based on the route of administration the market is segmented into:
Based on end users the market is segmented into:
Hospital pharmacies, retail pharmacies, and online pharmacies are the three types of pharmacies that make up the market based on the distribution channel. In 2019, the hospital pharmacies segment dominated the world market. Nonetheless, the expansion of the retail pharmacy market might be attributed to patients' increasing demand for these establishments. Due to the growing prevalence of online pharmacies in emerging countries, the segment of online pharmacies is estimated to see a profitable CAGR over the forecast timeframe.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses